Outcome

This study offers promising evidence that hyperbaric oxygen therapy (HBOT) at a mild pressure (1.3 ATA) can significantly improve cognitive deficits caused by mold exposure. After ten sessions of mHBOT the 15 subjects suffering from attention deficit disorder and slowed reaction times due to mold exposure experienced notable improvements.

Introduction

Exposure to mold toxins can have a detrimental impact on cognitive functions including attention span and reaction time. This study investigates whether hyperbaric oxygen therapy (HBOT) can improve these cognitive deficits in individuals exposed to mold. Fifteen participants who had developed attention deficit disorder (ADD) due to mold exposure were involved in the study. These cognitive impairments were measured using the Test of Variables of Attention (TOVA) an objective tool for assessing attention span and reaction time.

Participants underwent ten sessions of mild hyperbaric oxygen therapy (mHBOT) at a pressure of 1.3 atmospheres absolute (ATA). This pressure is lower than traditional HBOT which typically uses 2-3 ATA. The study found significant improvements in attention span reaction time consistency and overall cognitive function as measured by TOVA. The results indicate that mHBOT may offer a promising treatment for cognitive deficits related to mold exposure fostering better cognitive health in affected individuals.

Results

The study evaluated the effects of mild hyperbaric oxygen therapy (mHBOT) at 1.3 atmosphere absolute (ATA) on cognitive deficits caused by mold exposure in 15 subjects. These subjects had developed attention deficit disorder (ADD) and other cognitive impairments due to mold toxins a condition assessed using the Test of Variables of Attention (TOVA) which measures attention span and reaction time objectively.

Following ten sessions of mHBOT significant improvements were observed in multiple cognitive domains. Specifically participants showed marked enhancements in attention span reaction time and consistency as well as overall performance on the TOVA. These results were statistically significant with p-values less than 0.05 across all measured parameters.

These findings suggest that mHBOT can effectively alleviate cognitive deficits induced by mold exposure supporting its potential as a therapeutic approach for improving cognitive function in affected individuals. The improvements in cognitive performance underscore the therapeutic promise of mHBOT in treating the detrimental cognitive effects associated with mold toxins.

Conclusion

In conclusion this study provides compelling evidence that hyperbaric oxygen therapy (HBOT) at a mild pressure of 1.3 ATA significantly enhances cognitive functions impaired by mold exposure. The subjects demonstrated marked improvements in attention span reaction time consistency and overall cognitive performance after undergoing ten mHBOT sessions. These findings highlight the potential of HBOT as an effective therapeutic approach for mitigating cognitive deficits induced by mold toxicity. Given the promising results future research should focus on larger and more diverse populations to validate these outcomes and further explore HBOT’s efficacy in treating mold-related cognitive impairments.